相关实验视频
Updated: Jun 7, 2025

05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
13.1K
动脉样硬化中的炎症:病理生理学和机制
Amir Ajoolabady1, Domenico Pratico2, Ling Lin3,4
1Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Cell death & disease
|November 11, 2024
概括
炎症是动脉样硬化的关键,动脉样硬化是心血管疾病 (CVD) 的主要原因. 了解它的分子和细胞基础可以揭示治疗冠状动脉疾病等疾病的新治疗点.
科学领域:
- 心血管科学 心血管科学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 动脉样硬化是心血管疾病 (CVD) 的主要驱动因素,包括冠状动脉疾病和心力衰竭.
- 炎症在动脉样硬化斑块的发展和进展中起着至关重要的作用.
- 对动脉样硬化炎症的临床前研究对于确定新的治疗策略至关重要.
研究的目的:
- 批判性地审查和讨论最近的动脉样硬化炎症的分子和细胞机制.
- 确定白细胞中导致斑块炎症的信号通路和炎症反应.
- 突出潜在的治疗点,并评估目前对动脉样硬化炎症的干预措施.
主要方法:
- 文献审查和现有研究的批判性讨论.
- 对参与炎症反应的分子和细胞机制的分析.
- 评估巨细胞和白细胞中的信号级联.
主要成果:
- 炎症是动脉样硬化病原体的核心.
- 特定的信号级联和白细胞反应驱动斑块炎症.
- 已经确定了新的治疗点和抗炎机制.
结论:
- 对动脉样硬化炎症机制的深入了解对于开发新疗法至关重要.
- 向巨细胞和白细胞中的炎症途径提供了治疗潜力.
- 需要进一步的研究来优化预防和治疗心血管疾病的抗炎策略.
相关概念视频
Inflammation
52.8K
Overview
52.8K
Myocarditis I: Introduction
2
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Inflammatory Response
1.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management
359
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
359

